Fine-Tuning TLR-7-Based Therapy for Functional HBV Cure.
Antonio BertolettiNina Le BertPublished in: Hepatology communications (2019)
This is an invited editorial on the editorial on the original manuscript HEP4-19-0099.R1" "Liver-targeted TLR7 agonist combined with Entecavir promotes a functional cure in the woodchuck model of chronic HBV."